Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience

por Krejci, Marta, Pour, Ludek, Adam, Zdenek, Sandecka, Viera, Stork, Martin, Sevcikova, Sabina, Krejci, Martin, Knechtova, Zdenka, Kral, Zdenek
Publicado en Ann Hematol (2021)

Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma

por Ludwig, Heinz, Kasparu, Hedwig, Leitgeb, Clemens, Rauch, Elisabeth, Linkesch, Werner, Zojer, Niklas, Greil, Richard, Seebacher, Adelheid, Pour, Ludek, Weißmann, Adalbert, Adam, Zdeněk
Publicado 2014

Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse

por Pour, Ludek, Sevcikova, Sabina, Greslikova, Henrieta, Kupska, Renata, Majkova, Petra, Zahradova, Lenka, Sandecka, Viera, Adam, Zdenek, Krejci, Marta, Kuglik, Petr, Hajek, Roman
Publicado 2014

Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma

por Ludwig, Heinz, Adam, Zdenek, Tóthová, Elena, Hajek, Roman, Labar, Boris, Egyed, Miklós, Spicka, Ivan, Gisslinger, Heinz, Drach, Johannes, Kuhn, Ingrid, Hinke, Axel, Zojer, Niklas
Publicado 2010

Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study

por Ludwig, Heinz, Rauch, Elisabeth, Kuehr, Thomas, Adam, Zdeněk, Weißmann, Adalbert, Kasparu, Hedwig, Autzinger, Eva-Maria, Heintel, Daniel, Greil, Richard, Poenisch, Wolfram, Müldür, Ercan, Zojer, Niklas
Publicado en Haematologica (2015)

Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance

por Kubiczkova, Lenka, Kryukov, Fedor, Slaby, Ondrej, Dementyeva, Elena, Jarkovsky, Jiri, Nekvindova, Jana, Radova, Lenka, Greslikova, Henrieta, Kuglik, Petr, Vetesnikova, Eva, Pour, Ludek, Adam, Zdenek, Sevcikova, Sabina, Hajek, Roman
Publicado 2014

Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma

por Besse, Lenka, Sedlarikova, Lenka, Kryukov, Fedor, Nekvindova, Jana, Radova, Lenka, Slaby, Ondrej, Kuglik, Petr, Almasi, Martina, Penka, Miroslav, Krejci, Marta, Adam, Zdenek, Pour, Ludek, Sevcikova, Sabina, Hajek, Roman
Publicado en PLoS One (2015)

Genome-Wide Screening of Cytogenetic Abnormalities in Multiple Myeloma Patients Using Array-CGH Technique: A Czech Multicenter Experience

por Smetana, Jan, Frohlich, Jan, Zaoralova, Romana, Vallova, Vladimira, Greslikova, Henrieta, Kupska, Renata, Nemec, Pavel, Mikulasova, Aneta, Almasi, Martina, Pour, Ludek, Adam, Zdenek, Sandecka, Viera, Zahradová, Lenka, Hajek, Roman, Kuglik, Petr
Publicado 2014

Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neurop...

por Minarik, Jiri, Pavlicek, Petr, Pour, Ludek, Pika, Tomas, Maisnar, Vladimir, Spicka, Ivan, Jarkovsky, Jiri, Krejci, Marta, Bacovsky, Jaroslav, Radocha, Jakub, Straub, Jan, Kessler, Petr, Wrobel, Marek, Walterova, Lenka, Sykora, Michal, Obernauerova, Jarmila, Brozova, Lucie, Gregora, Evzen, Adamova, Dagmar, Gumulec, Jaromir, Adam, Zdenek, Scudla, Vlastimil, Hajek, Roman
Publicado en PLoS One (2015)